Huanye Mo

883 total citations
24 papers, 561 citations indexed

About

Huanye Mo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huanye Mo has authored 24 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huanye Mo's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Huanye Mo is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Huanye Mo collaborates with scholars based in China and Belgium. Huanye Mo's co-authors include Kangsheng Tu, Tianxiang Chen, Runkun Liu, Liankang Sun, Yongshen Niu, Liang Wang, Bowen Yao, Qiuran Xu, Qingguang Liu and Xuelian Xiao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Huanye Mo

24 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanye Mo China 16 404 350 108 76 50 24 561
Geum Ok Baek South Korea 11 321 0.8× 304 0.9× 90 0.8× 72 0.9× 95 1.9× 18 468
Guijuan Luo China 10 443 1.1× 317 0.9× 181 1.7× 133 1.8× 55 1.1× 12 645
Sze Keong Tey Hong Kong 12 294 0.7× 217 0.6× 67 0.6× 75 1.0× 27 0.5× 19 447
Heping Kan China 12 290 0.7× 221 0.6× 72 0.7× 89 1.2× 18 0.4× 18 425
Kwan Man Hong Kong 5 543 1.3× 199 0.6× 51 0.5× 73 1.0× 83 1.7× 5 688
Yingru Zhi China 9 405 1.0× 337 1.0× 53 0.5× 40 0.5× 28 0.6× 11 498
Dianke Chen China 13 299 0.7× 257 0.7× 76 0.7× 186 2.4× 54 1.1× 25 519
Meisongzhu Yang China 12 386 1.0× 220 0.6× 114 1.1× 104 1.4× 14 0.3× 16 524
Baocun Sun China 8 298 0.7× 231 0.7× 44 0.4× 100 1.3× 25 0.5× 9 399

Countries citing papers authored by Huanye Mo

Since Specialization
Citations

This map shows the geographic impact of Huanye Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanye Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanye Mo more than expected).

Fields of papers citing papers by Huanye Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanye Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanye Mo. The network helps show where Huanye Mo may publish in the future.

Co-authorship network of co-authors of Huanye Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Huanye Mo. A scholar is included among the top collaborators of Huanye Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanye Mo. Huanye Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mo, Huanye, Nan Yang, Jiaqi Han, et al.. (2024). USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop. Cancer Letters. 589. 216832–216832. 6 indexed citations
2.
Wang, Huanhuan, Runkun Liu, Huanye Mo, et al.. (2023). A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection. Frontiers in Oncology. 13. 1133807–1133807. 8 indexed citations
3.
Zhao, Wei, Huanye Mo, Runkun Liu, et al.. (2022). Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression. British Journal of Cancer. 127(2). 202–210. 18 indexed citations
4.
Li, Yue, Huanye Mo, Jun Wang, et al.. (2022). Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma. Frontiers in Immunology. 13. 1066773–1066773. 16 indexed citations
5.
Li, Yue, Huanye Mo, Shengli Wu, Xin Liu, & Kangsheng Tu. (2022). A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 9. 801959–801959. 30 indexed citations
6.
Liu, Zhikui, Huanye Mo, Runkun Liu, et al.. (2021). Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression. Cell Death and Disease. 12(12). 1134–1134. 49 indexed citations
7.
Chen, Tianxiang, Runkun Liu, Yongshen Niu, et al.. (2021). HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway. Cell Death and Disease. 12(12). 1152–1152. 46 indexed citations
8.
Tu, Kangsheng, et al.. (2021). Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. International Journal of Medical Sciences. 18(9). 2030–2041. 7 indexed citations
9.
Liu, Runkun, et al.. (2021). Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B. International Journal of Biological Sciences. 17(13). 3331–3342. 25 indexed citations
10.
11.
Wang, Jun, Runkun Liu, Yufeng Wang, et al.. (2021). Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression. Journal of Cancer. 12(17). 5320–5330. 5 indexed citations
12.
Wang, Liang, Liankang Sun, Runkun Liu, et al.. (2021). Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Journal of Experimental & Clinical Cancer Research. 40(1). 72–72. 58 indexed citations
13.
He, Haibin, et al.. (2020). Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway. Biochemical and Biophysical Research Communications. 533(4). 886–892. 24 indexed citations
14.
Yao, Bowen, et al.. (2020). BICD1 functions as a prognostic biomarker and promotes hepatocellular carcinoma progression. Pathology - Research and Practice. 216(4). 152858–152858. 5 indexed citations
15.
Xiao, Xuelian, Huanye Mo, & Kangsheng Tu. (2020). CTNNB1 mutation suppresses infiltration of immune cells in hepatocellular carcinoma through miRNA-mediated regulation of chemokine expression. International Immunopharmacology. 89(Pt A). 107043–107043. 28 indexed citations
16.
Chen, Tianxiang, et al.. (2020). BRD8, which is negatively regulated by miR-876–3p, promotes the proliferation and apoptosis resistance of hepatocellular carcinoma cells via KAT5. Archives of Biochemistry and Biophysics. 693. 108550–108550. 12 indexed citations
17.
Yang, Xue, Liankang Sun, Liang Wang, et al.. (2019). LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Biomedicine & Pharmacotherapy. 118. 109386–109386. 58 indexed citations
18.
Wang, Liang, Huanye Mo, Yufeng Wang, et al.. (2019). MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Biomedicine & Pharmacotherapy. 118. 109267–109267. 21 indexed citations
19.
Wang, Liang, Bowen Yao, Wei Yang, et al.. (2019). MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP. Biomedicine & Pharmacotherapy. 118. 109343–109343. 22 indexed citations
20.
Yang, Xue, Bowen Yao, Yongshen Niu, et al.. (2019). Hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122–5p/CTNND2 axis. Biochemical and Biophysical Research Communications. 518(2). 239–245. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geum Ok Baek Breakdown of academic impact, for papers by Guijuan Luo Breakdown of academic impact, for papers by Sze Keong Tey Breakdown of academic impact, for papers by Heping Kan Breakdown of academic impact, for papers by Kwan Man Breakdown of academic impact, for papers by Yingru Zhi Breakdown of academic impact, for papers by Dianke Chen Breakdown of academic impact, for papers by Meisongzhu Yang Breakdown of academic impact, for papers by Baocun Sun
Rankless by CCL
2026